Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block Effects in Ventricular Tachycardia
NCT05377216Phase 1Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Sep 2022
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in ventricular tachycardia (VT), sponsored by University of Pennsylvania. Primary endpoint: Ventricular Effective Refractory Period at 30 minutes. Started Sep 2022; status: recruiting.
02
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT05377216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05377216.